[Changes in the lung in lymphogranulomatosis and the results of cytostatic treatment].
D000903:Antibiotics, Antineoplastic / Q000627:therapeutic use*; D003520:Cyclophosphamide / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006689:Hodgkin Disease / Q000188:drug therapy / Q000473:pathology*; D008168:Lung / Q000473:pathology*; D008198:Lymph Nodes / Q000473:pathology; D010996:Pleural Effusion / Q000175:diagnosis; D011014:Pneumonia / Q000175:diagnosis; D011344:Procarbazine / Q000627:therapeutic use; D011832:Radiation Injuries / Q000175:diagnosis; D012075:Remission, Spontaneous; D014397:Tuberculosis, Pulmonary / Q000150:complications; D014747:Vinblastine / Q000627:therapeutic use
D000903:Antibiotics, Antineoplastic; D011344:Procarbazine; D014747:Vinblastine; D003520:Cyclophosphamide
Lungenveränderungen bei der Lymphogranulomatose und die Ergebnisse der zytostatischen Behandlung